Diagnostic and Interventional Cardiology

Dr. Rami Kahwash, director of Ohio State’s Heart and Vascular Research Organization and a professor of clinical medicine in the Ohio State College of Medicine.

Ohio State First in World to Participate in Trial Confirming Efficacy of Novel Heart Failure Treatment

December 9, 2022 — The Ohio State University Wexner Medical Center is first in the world to randomize a patient in a ...

December 09, 2022

News | Cardiovascular Clinical Studies

Ninerafaxstat Showcased at the 19th Annual Global Cardio Vascular Clinical Trialists (CVCT) Forum with Focus on the Potential in Non-obstructive Hypertrophic Cardiomyopathy

December 9, 2022 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies ...

December 09, 2022

Cardiac care should follow the patient on a virtual journey and deliver high-fidelity insights to care providers, eliminating the gaps in data transmission

News | Remote Monitoring

With Minutes Between Life and Death, Continuous Remote ECG Monitoring Saves Lives

December 8, 2022 — Heart disease is the number one killer in the U.S., and high-fidelity monitoring is the beginning of ...

December 08, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Along with physician leaders and members, the society has helped the subspecialty officially join NRMP’s Medical Specialties Matching Program in 2025

News | SCAI

SCAI Leads the Way for Interventional Cardiology to Join “The Match”

December 8, 2022 — The Society for Cardiovascular Angiography & Interventions (SCAI), a leading nonprofit medical ...

December 08, 2022

Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint

News | Cardiovascular Clinical Studies

Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL (bempedoic acid) Meets Primary Endpoint

December 8, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...

December 08, 2022

News | Ultrasound Imaging

Butterfly Announces CEO Transition

December 8, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...

December 08, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Brian Arends, left, checks the electrical resistivity and conductivity of the wearable heart monitor as Zheng Yan, center, and Yadong Xu, right, observe in Yan's lab. The lab is located in the Roy Blunt NextGen Precision Health building. Pate McCuien/University of Missouri

News | Wearables

University of Missouri Researchers Design New Heart Health Wearable

December 7, 2022 — While heart disease is a leading cause of death in the United States, most people can be treated with ...

December 07, 2022

News | Clinical Decision Support

Computerized Decision Support System Helps to Reduce Cardiovascular Risk Factors in Patients with Diabetes

December 7, 2022 — Compared with team-based care alone, the addition of a computerized clinical decision support system ...

December 07, 2022

Allogeneic CardiALLO therapy for heart failure to complement autologous cell therapy currently enrolling in Phase III CardiAMP Heart Failure clinical trial

News | Heart Failure

BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure

December 7, 2022 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

December 07, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

News | Cardiovascular Business

Ultromics Receives FDA Clearance for AI-based Platform for Echocardiography

December 7, 2022 — Ultromics has announced that its EchoGo Heart Failure, an artificial intelligence (AI) platform for ...

December 07, 2022

Designed to assist physicians detect findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia.

News | Endovascular Aortic Repair

Imagen Technologies Announces FDA Clearance of Aorta-CAD

December 5, 2022 — Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the ...

December 05, 2022

The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices,

News | Catheters

Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) Shortage - Letter to Health Care Providers

December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...

December 05, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Feature | Cardiovascular Business